STERIS plc (STE)
NYSE: STE · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Dublin, IE · filing with the SEC since 2018
Grade6.7
◀ Past 7.8● Present 7.1▶ Future 5.1
Who owns STERIS plc
As filed with the SECHolders of 5% or more
3
Vanguard Capital Management holds 7.48% of Common Stock, as its SCHEDULE 13G filed Apr 30, 2026 says.
Directors and officers
18
report now, of 31 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Vanguard Capital Management
SCHEDULE 13G · filed Apr 30, 2026 · Common Stock
State Street Corporation
SCHEDULE 13G · filed May 12, 2026 · COMMON STOCK
Vanguard Portfolio Management
SCHEDULE 13G · filed Apr 29, 2026 · Common Stock
Massachusetts Financial Services Company
SCHEDULE 13G/A · filed Nov 4, 2025 · Common Stock · reported falling below 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
What STE reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Becton, Dickinson and Company
A company bought · acquisition · Mar 2024 · owns, named in the 10-K filed May 29, 2026
BD Acquisition
A company bought · asset acquisition · owns, named in the 10-K filed May 29, 2026
160 subsidiaries in 37 countries, from the list filed with the 10-K filed May 29, 2026.
Insider tradesForm 4
14sales
0purchases
3sales on a scheduled plan
8people selling
$8.6Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window8 of 31 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Sohi Mohsen | director | 3 | $2.2M | 0 | 0 | $0 |
| Burton Karen L | Sr. Vice Pres., CFO | 1 | $1.5M | 0 | 0 | $0 |
| Madsen Julia | Sr. VP and GM, Life Sciences | 2 | $1.3M | 0 | 0 | $0 |
| Tamaro Renato | V.P. & Corporate Treasurer | 3 | $1.3M | 0 | 0 | $0 |
| Carestio Daniel A | President and CEO | 2 | $900,000 | 2 | 0 | $0 |
| Feldmann Cynthia L | director | 1 | $700,000 | 0 | 0 | $0 |
| Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | 1 | $300,000 | 1 | 0 | $0 |
| Breeden Richard C | director | 1 | $300,000 | 0 | 0 | $0 |